Sign In
Buy SOLV
$74.56
-2.00 (-2.61%)
At Close: Jun 17, 2026
Solventum's second-quarter profit falls 70% on higher expenses
07:08pm, Thursday, 08'th Aug 2024
3M spin-off Solventum's second-quarter profit fell more than 70% on Thursday, hurt by limited sales growth of its wound care and surgical sterilization products and higher expenses, as it navigates fu
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance
04:05pm, Thursday, 08'th Aug 2024
Separation activities and business continuity on track Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56 Gene
4 Dividend Aristocrats To Buy In August And More To Watch
12:21pm, Tuesday, 06'th Aug 2024
“Dividend Aristocrats
Curreen Capital: Ugly Ducklings Selling At An Attractive Price
10:10pm, Saturday, 27'th Jul 2024
We were more active than usual in the quarter, buying shares that were available at very attractive prices. All in, we have ugly ducklings - high returns on capital, cash cow spinoffs, working through
Activist Trian has a few levers to pull to build shareholder value at Solventum
08:55am, Saturday, 27'th Jul 2024
Since its spinoff from 3M, Solventum has been under-covered and misunderstood by the market.
SOLV Stock Alert: Solventum Pops as Activist Investor Trian Capital Takes Stake
11:48am, Tuesday, 23'rd Jul 2024
Solventum (NYSE: SOLV ) stock is up on Tuesday after activist investor Trian Capital took a stake in the healthcare company. According to insider sources, Trian Capital has taken a large stake in the
Solventum Stock Jumps as Activist Trian Discloses Stake
05:48pm, Monday, 22'nd Jul 2024
The move comes just months after 3M spun off the healthcare product company.
Nelson Peltz's Trian said to build stake in 3M spinoff Solventum, Bloomberg News reports
05:34pm, Monday, 22'nd Jul 2024
Activist investor Nelson Peltz's Trian Fund Management has built a stake in 3M's healthcare spinoff Solventum , Bloomberg News reported on Monday, citing people with knowledge of the matter, sending s
Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
06:50am, Tuesday, 16'th Jul 2024
ST. PAUL, Minn., July 16, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets close.
ST. PAUL, Minn., July 2, 2024 /PRNewswire/ -- Solventum today announced that U.S. News & World Report is expanding its use of Solventum's 3M™ Ambulatory Potentially Preventable Complications (
ST. PAUL, Minn., June 24, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), [formerly 3M Health Care] today announced a new artificial intelligence (AI)-driven payment integrity and revenue cycle solutio
Contrarian Plays: 3 Stocks to Buy When Analysts Say ‘Sell'
03:01pm, Tuesday, 18'th Jun 2024
Wall Street loves winners. They enjoy backing stocks that are rising and want to avoid stocks that are falling.
3M Company: Solventum Spinoff Creates More Upside Potential
02:49pm, Monday, 17'th Jun 2024
Despite the strong rally recently, I see more upside for 3M Company stock prices. The top drivers include the Solventum Corporation spin-off and the settlement of its legacy lawsuits, both enhancing
Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"
06:55am, Friday, 07'th Jun 2024
ST. PAUL, Minn., June 7, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) has been notified that TRC Capital Investment Corporation ("TRC") made an unsolicited "mini-tender offer" to purchase up to 2,000,0
TRC Amends Its Tender Offer for Solventum Corporation
09:00am, Thursday, 06'th Jun 2024
TORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- TRC Capital Investment Corporation (TRC) announced today that based on current market conditions, TRC has amended the terms of its tender offer for up to 2,0
